MeSH D060585 - fusariosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Voriconazole | Voriconazole | 2012-04-06 | |||
| Glenmark Pharmaceuticals | Voriconazole | Voriconazole | 2015-09-02 | |||
| Mylan | Voriconazole | Voriconazole | 2010-04-22 | |||
| Sandoz | Voriconazole | Voriconazole | 2012-05-30 | |||
| Pfizer | Voriconazole | Vfend | 2002-03-19 | $187 M | Y2023 | |
| Aurobindo Pharma | Voriconazole | Voriconazole | 2016-01-22 | |||
| Ajanta Pharma | Voriconazole | Voriconazole | 2016-05-24 | |||
| Rising Pharmaceuticals | Voriconazole | Voriconazole | 2013-05-28 | |||
| Zydus Therapeutics | Voriconazole | Voriconazole | 2016-05-24 | |||
| Prinston Pharmaceutical | Voriconazole | Voriconazole | 2016-08-08 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use